Study tests imaging and tissue markers in brain lymphoma
Part of Brain & nervous system, Cancer clinical trials.
This study looks at how primary central nervous system (CNS) lymphoma can be identified and tracked using scans and molecular (tissue/biomarker) tests. It may help doctors better understand your disease and choose the best next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or a legal representative) can provide informed consent for study participation.
- You have a confirmed diagnosis of primary CNS lymphoma (brain/spinal cord lymphoma).
- You have not had treatment that targets the CNS before (steroids before scans/biopsy are allowed).
- You are 18 years old or older.
- Your lymphoma is only in the CNS (not found outside the brain/spinal cord).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain biopsy and spinal fluid (lumbar puncture) tests to better diagnose and understand how well treatments may work for certain lymphomas in the brain. It may help doctors match the right therapy by studying what the disease looks like in the body and brain.
This trial looks at the immune system and metabolism of people with primary central nervous system lymphoma (a type of brain cancer) to find differences that might help with future treatments. It does not test a new drug, but collects samples and medical information.
This trial tests a new type of imaging scan to see if it can better detect and monitor brain lymphoma. It may help doctors tailor treatment by seeing how the cancer responds early on.
This study looks at genetic and molecular features of primary central nervous system diffuse large B-cell lymphoma to better understand the disease. It may help guide future treatments.
This study tests whether a blood test (ctDNA) can help doctors see how well treatment is working for people with a type of brain lymphoma (PCNSL) who are getting their first treatment with a cure in mind.
This Phase 2 trial studies methotrexate, tafasitamab, lenalidomide, and rituximab for primary B-cell lymphoma that starts in the brain/spinal fluid. It aims to see how well this combination works for people who cannot have certain high-dose stem cell treatment.
Hear when a new CNS Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.